Pediatrix Medical Group (MD) Shows Fast-paced Momentum But Is Still a Bargain Stock
Pediatrix Medical Group (MD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
All You Need to Know About Pediatrix Medical Group (MD) Rating Upgrade to Strong Buy
Pediatrix Medical Group (MD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Here Is Why Bargain Hunters Would Love Fast-paced Mover Pediatrix Medical Group (MD)
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Pediatrix Medical Group (MD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Pediatrix (MD) Q2 Earnings Top on Stable Volumes, Shares Up 7.4%
Pediatrix's (MD) second-quarter earnings benefit from stable patient volumes. Rising expenses act as a partial offset.
Pediatrix Medical Group, Inc. (MD) Q2 2024 Earnings Call Transcript
Pediatrix Medical Group, Inc. (NYSE:MD ) Q2 2024 Earnings Conference Call August 6, 2024 9:00 AM ET Company Participants Charles Lynch - SVP, Finance & Strategy Jim Swift - CEO Marc Richards - CFO Kasandra Rossi - SVP, Financial Reporting & Assistant Treasurer Conference Call Participants A.J. Rice - UBS Nur Robleh - Jefferies Benjamin Shaver - Deutsche Bank Kevin Fischbeck - Bank of America Operator Ladies and gentlemen, thank you for standing by.
Pediatrix Medical Group (MD) Q2 Earnings Surpass Estimates
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.39 per share a year ago.
Why Is Pediatrix Medical Group (MD) Down 15.9% Since Last Earnings Report?
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
